193 related articles for article (PubMed ID: 10639189)
1. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
Spiotto MT; Chung TD
Prostate; 2000 Feb; 42(3):186-95. PubMed ID: 10639189
[TBL] [Abstract][Full Text] [Related]
2. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP.
Spiotto MT; Chung TD
Prostate; 2000 Feb; 42(2):88-98. PubMed ID: 10617865
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
Kim J; Adam RM; Solomon KR; Freeman MR
Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .
Lou W; Ni Z; Dyer K; Tweardy DJ; Gao AC
Prostate; 2000 Feb; 42(3):239-42. PubMed ID: 10639195
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
[TBL] [Abstract][Full Text] [Related]
7. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.
Nakajima K; Yamanaka Y; Nakae K; Kojima H; Ichiba M; Kiuchi N; Kitaoka T; Fukada T; Hibi M; Hirano T
EMBO J; 1996 Jul; 15(14):3651-8. PubMed ID: 8670868
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
Lee SO; Lou W; Johnson CS; Trump DL; Gao AC
Prostate; 2004 Aug; 60(3):178-86. PubMed ID: 15176047
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
Deeble PD; Murphy DJ; Parsons SJ; Cox ME
Mol Cell Biol; 2001 Dec; 21(24):8471-82. PubMed ID: 11713282
[TBL] [Abstract][Full Text] [Related]
10. Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells.
Zhang XQ; Kondrikov D; Yuan TC; Lin FF; Hansen J; Lin MF
Oncogene; 2003 Oct; 22(43):6704-16. PubMed ID: 14555984
[TBL] [Abstract][Full Text] [Related]
11. AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells.
Natani S; Dhople VM; Parveen A; Sruthi KK; Khilar P; Bhukya S; Ummanni R
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119085. PubMed ID: 34171447
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation.
Wang Q; Horiatis D; Pinski J
Int J Cancer; 2004 Sep; 111(4):508-13. PubMed ID: 15239127
[TBL] [Abstract][Full Text] [Related]
13. Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.
Moritz T; Venz S; Junker H; Kreuz S; Walther R; Zimmermann U
Tumour Biol; 2016 Aug; 37(8):10435-46. PubMed ID: 26846108
[TBL] [Abstract][Full Text] [Related]
14. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.
Zelivianski S; Verni M; Moore C; Kondrikov D; Taylor R; Lin MF
Biochim Biophys Acta; 2001 May; 1539(1-2):28-43. PubMed ID: 11389966
[TBL] [Abstract][Full Text] [Related]
15. Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice.
DeMiguel F; Lee SO; Lou W; Xiao X; Pflug BR; Nelson JB; Gao AC
Prostate; 2002 Jul; 52(2):123-9. PubMed ID: 12111703
[TBL] [Abstract][Full Text] [Related]
16. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
Berenguer C; Boudouresque F; Dussert C; Daniel L; Muracciole X; Grino M; Rossi D; Mabrouk K; Figarella-Branger D; Martin PM; Ouafik L
Oncogene; 2008 Jan; 27(4):506-18. PubMed ID: 17637748
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
[TBL] [Abstract][Full Text] [Related]
20. Tumor protein D52 (isoform 3) induces NF-κB - STAT3 mediated EMT driving neuroendocrine differentiation of prostate cancer cells.
Sruthi KK; Natani S; Ummanni R
Int J Biochem Cell Biol; 2024 Jan; 166():106493. PubMed ID: 37935328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
